Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Both mouse and rat models are effective for testing alopecia areata treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.